Skip to content

US · CLB · OIL & GAS EQUIPMENT & SERVICES

Core Laboratories N.V. (CLB) intrinsic value and stock valuation

$7.76as of 2026-11-21 · Mkt cap 504.76M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Core Laboratories N.V. DCF and intrinsic value

InvestorsCraft values CLB with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CLB’s statements →

Core Laboratories N.V. Graham Number

Graham Number: $9.17d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Energy · Oil & Gas Equipment & Services Houston, TX 77040 corelab.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$526.5M+1.6% 5y CAGRd
20112025
Net income
$29.7M
20112025
Free cash flow
$22.3M-13.5% 5y CAGRd
20112025
Total equity
$272.2M+29.2% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$526.5M$523.9M$509.8M$489.7M$470.3M
Operating income$50.5M$58.6M$54.6M$41.5M$45.3M
Net income$29.7M$31.4M$36.7M$19.5M$19.7M
EPSd$638.1K$658.4K$771.7K$415.5K$422.6K
Operating cash flow$37M$56.4M$24.8M$25M$36.6M
Capital expenditure-$-14.74M-$-13.03M-$-10.58M-$-10.22M-$-13.54M
Free cash flow$22.3M$43.4M$14.2M$14.7M$23M
Total assets$584M$590.4M$586.4M$578.4M$580.9M
Total debt$164M$180.1M$215.4M$222.4M$250.3M
Net debt$141.3M$161M$200.3M$207M$232.6M
Total equity$272.2M$257.7M$229.8M$189M$161M
Cash and short-term investments$22.7M$19.2M$15.1M$15.4M$17.7M
Income statement
20252024202320222021
Revenue$526.5M$523.9M$509.8M$489.7M$470.3M
Cost of revenue$432.2M$435.5M$415.7M$410.8M$386.4M
Gross profit$94.3M$88.4M$94.1M$78.9M$83.8M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$44.2M$38.6M$38.9M$38.1M$44.2M
Other expenses-$-430K-$-8.78M$520K-$-720K-$-5.59M
Operating expenses$43.8M$29.8M$39.4M$37.4M$38.6M
Cost and expenses$476M$465.3M$455.2M$448.2M$425M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$10.6M$12.4M$13.4M$11.6M$9.15M
Depreciation and amortization$14.7M$15M$15.8M$17.2M$18.5M
Ebitda$71.1M$73.5M$70.4M$58.7M$63.8M
Operating income$50.5M$58.6M$54.6M$41.5M$45.3M
Total other income/expenses, net-$-4.59M-$-12.37M-$-13.43M-$-11.57M-$-9.15M
Income before tax$45.9M$46.2M$41.2M$30M$36.1M
Income tax expense$15.5M$14M$4.18M$10.3M$15.9M
Net income$29.7M$31.4M$36.7M$19.5M$19.7M
Weighted average shares outstanding$46.5M$46.9M$46.7M$46.3M$46M
Weighted average diluted shares outstanding$46.5M$47.7M$47.5M$46.8M$46.7M
Balance sheet
20252024202320222021
Cash and short-term investments$22.7M$19.2M$15.1M$15.4M$17.7M
Net receivables$120.8M$127.4M$123.1M$115.1M$106.7M
Inventory$54.5M$59.4M$71.7M$60.5M$45.4M
Total current assets$214.7M$226.6M$223.1M$211.7M$189.1M
Property, plant and equipment, net$153.8M$153.6M$153.5M$157.4M$172.3M
Goodwill and intangible assets$112.9M$105.9M$106.4M$106.9M$107.6M
Long-term investments$4.43M$5.08M$4.84M$4.45M$4.16M
Total non-current assets$369.4M$363.8M$363.3M$366.7M$391.8M
Total assets$584M$590.4M$586.4M$578.4M$580.9M
Accounts payable$37.3M$34.6M$33.5M$45.9M$29.7M
Short-term debt$11.5M$10.7M$10.2M$11.7M$12.3M
Deferred revenue$5.55M$9.33M$4.75M$5.94M$7.76M
Total current liabilities$106M$97.6M$88.1M$103.1M$90.8M
Long-term debt$152.6M$169.5M$205.2M$210.7M$237.9M
Deferred revenue, non-current$29.4M$0.00$30.5M$31.8M$39.1M
Total non-current liabilities$205.8M$235.1M$268.5M$286.3M$329.1M
Capital lease obligations$53.8M$54M$52.3M$50M$61.6M
Total liabilities$311.8M$332.7M$356.6M$389.4M$419.9M
Common stock$470K$470K$470K$1.19M$1.19M
Retained earnings$172.7M$150.3M$120.8M$86M$68.4M
Accumulated other comprehensive income (loss)-$-5.81M-$-5.77M-$-4.97M-$-3.78M-$-10.13M
Total equity$272.2M$257.7M$229.8M$189M$161M
Total investments$4.43M$5.08M$4.84M$4.45M$4.16M
Total debt$164M$180.1M$215.4M$222.4M$250.3M
Net debt$141.3M$161M$200.3M$207M$232.6M
Cash flow statement
20252024202320222021
Net income$30.4M$32.2M$37M$19.7M$20.2M
Depreciation and amortization$14.7M$15M$15.8M$17.2M$18.5M
Stock-based compensation$7.14M$3.75M$14M$7.76M$19.1M
Change in working capital-$-14.53M$7.88M-$-28.77M-$-25.02M-$-24.25M
Accounts receivable-$-4.95M-$-3.61M-$-2.62M-$-10.08M-$-13.52M
Inventory$2.64M$9.37M-$-12.98M-$-14.86M-$-4.55M
Accounts payable$480K$520K-$-12.88M$15.4M$6.57M
Net cash provided by operating activities$37M$56.4M$24.8M$25M$36.6M
Investments in property, plant and equipment-$-14.74M-$-13.03M-$-10.58M-$-10.22M-$-13.54M
Acquisitions, net-$-1.24M$0.00$0.00$240K$870K
Net cash used for investing activities-$-2.23M-$-6.39M-$-6.65M-$-3.86M-$-10.22M
Common stock issued$0.00$0.00$0.00$0.00$60M
Common stock repurchased-$-12.43M-$-5.31M-$-2.2M-$-3.9M-$-8.26M
Dividends paid-$-1.87M-$-1.88M-$-1.87M-$-1.85M-$-1.83M
Net cash used for financing activities-$-31.25M-$-45.96M-$-18.45M-$-23.38M-$-22.46M
Net change in cash$3.54M$4.04M-$-310K-$-2.27M$3.9M
Cash at end of period$22.7M$19.2M$15.1M$15.4M$17.7M
Operating cash flow$37M$56.4M$24.8M$25M$36.6M
Capital expenditure-$-14.74M-$-13.03M-$-10.58M-$-10.22M-$-13.54M
Free cash flow$22.3M$43.4M$14.2M$14.7M$23M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Core Laboratories N.V.

        Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

        CEO
        Lawrence V. Bruno
        Employees
        3.3K
        Beta
        1.01

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Core Laboratories N.V. (CLB)?

        Core Laboratories N.V. (CLB) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CLB undervalued?

        CLB trades at a price of $7.76 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.